Indivior Considers Appeal Options For Suboxone Patent Ruling Read More
Indivior Posts Quarterly Loss As Suboxone Competitor Hits Market Share Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
Indivior Non-Exec Director Tatjana May To Step Down For New Career Read More
Positive Long-Term Safety Data From Indivior Sublocade Injection Study Read More
Indivior Withdraws Guidance As Covid-19 Hurts Drug Enrolment Read More
Indivior Encouraged By Results From Opioid Addiction Treatment Trial Read More
DIRECTOR DEALINGS SUMMARY: TalkTalk Executive Chair Spends GBP400,000 Read More
UK BROKER RATINGS SUMMARY: Investec Raises RBS To Buy From Hold Read More
UK WINNERS & LOSERS SUMMARY: Centrica Plunges After Swinging To Loss Read More
Indivior Sinks As It Warns Of 2020 Loss And Potential Legal Costs Read More
Indivior And Virginia Tech To Collaborate On Recover Study Extension Read More
Indivior Reports Positive Results From Sublocade Injection Analysis Read More
Indivior In Campaign To Ramp Up Opioid-Addiction Drug Awareness Read More
Indivior Third Quarter Profit Drops On Generic Competition In US Read More
Indivior Hires Ex-Shire Numbers Boss Hetherington As Non-Executive Read More
LONDON MARKET MIDDAY: FTSE Suffers As Pound Gains On Brexit Deal Hopes Read More
